✦ LIBER ✦

Randomised trial in HBeAg negative chronic hepatitis B of oral nucleoside analogues in combination with interferon

✍ Scribed by A. Alexopoulou; E. Zafiropoulou; A. Papakonstantinou; S.J. Hadziyannis

Book ID: 118568418
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 171 KB
Volume: 28
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(98)80650-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon alfa-2b alone or in

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

✍ Harry LA Janssen; Monika van Zonneveld; Hakan Senturk; Stefan Zeuzem; Ulus S Aka 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 95 KB

Lamivudine/pegylated interferon alfa-2b

Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B

✍ Themistoklis Vassiliadis; Konstantinos Tziomalos; Kalliopi Patsiaoura; Thomas Za 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Long term efficacy of interferon and thy

Long term efficacy of interferon and thymosin combination in comparison to lamivudine+interferon and interferon monotherapy in patients with HBEAG negative chronic hepatitis B

✍ M. Saruc; N. Ozden; N. Turkel; L.M. Hock; S. Ayhan; I. Tuzcuoglu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB

What Should Be the Endpoints of Oral The

What Should Be the Endpoints of Oral Therapy in HBeAg-positive Versus HBeAg-negative Patients with Chronic Hepatitis B

✍ Stephanos J. Hadziyannis, Dimitrios Vassilopoulos 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 123 KB

O.048 Treatment of chronic hepatitis B w

O.048 Treatment of chronic hepatitis B with the combination of pegylated interferon with a nucleoside/nucleotide analogue

✍ P. Marcellin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Long-term outcomes of thymosin-α1 and in

Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B

✍ Murat Saruc; Nuri Ozden; Nurten Turkel; Semin Ayhan; Lynette M. Hock; Isil Tuzcu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Hepatitis B e antibody (HbeAb) and hepatitis B virus (HBV) DNA positive chronic hepatitis is a clinical entity, distinct from classical hepatitis B e antigen (HbeAg) positive chronic hepatitis B. Our aim was to evaluate the long-term therapeutic efficacy of the combination of interferon alpha-2b and